Desloratadine - Hefei Industrial Pharmaceutical InstituteAlternative Names: Desloratadine citrate disodium
Latest Information Update: 04 Aug 2016
At a glance
- Originator Hefei Industrial Pharmaceutical Institute
- Class Antiallergics; Dibenzocycloheptenes; Nonsedating antihistamines; Piperidines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Allergic rhinitis
Most Recent Events
- 31 Dec 2015 Preclinical trials in Allergic rhinitis in China (Parenteral)